Financials

  • Market Capitalization 949.79 M
  • Employee 93
  • Founded 2011
  • CEO N/A
  • Website www.annexonbio.com
  • Headquarter Delaware, United States
  • FIGI BBG007QVDFG2
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-3.75
Rapporto prezzo/fatturato

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
2458
IMMX
Immix Biopharma, Inc. - Common Stock
13.98 USD-2.31%+5.03%+65.05%+507.83%1.00 B USD
2472
GERN
Geron Corporation - Common Stock
1.51 USD-1.31%-1.31%+4.86%+4.86%970.13 M USD
2486
ARDX
Ardelyx, Inc. - Common Stock
3.81 USD-0.26%-2.81%-24.70%-40.47%949.40 M USD
2487
DSGN
Design Therapeutics, Inc. - Common Stock
15.17 USD-0.52%-0.72%+27.05%+168.50%949.36 M USD

Notizie